Effect of dapagliflozin on colon cancer cell [Rapid Communication]
Authors:
- 1 January 2015
- journal article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 62 (12) , 1133-1137
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 9 references indexed in Scilit:
- Dapagliflozin: A new sodium–glucose cotransporter 2 inhibitor for treatment of type 2 diabetesAmerican Journal of Health-System Pharmacy, 2015
- UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer CellsPLOS ONE, 2013
- The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitusBritish Journal of Clinical Pharmacology, 2013
- Expression of glucose transporters in cancersBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2013
- Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion moleculeProceedings of the National Academy of Sciences, 2013
- Nucleobindin-2 Is a Positive Modulator of EGF-Dependent Signals Leading to Enhancement of Cell Growth and Suppression of Adipocyte DifferentiationEndocrinology, 2012
- Pharmacokinetic and Pharmacodynamic Modeling of the Effect of an Sodium-Glucose Cotransporter Inhibitor, Phlorizin, on Renal Glucose Transport in RatsDrug Metabolism and Disposition, 2011
- Cloning and Expression of Bovine Sodium/Glucose Cotransporter SGLT2Journal of Dairy Science, 2005
- Insulin Stimulates the Phosphorylation of the 66- and 52-Kilodalton Shc Isoforms by Distinct PathwaysEndocrinology, 1997